Lilly(Eli) & Company

NYSE: LLY
$725.72
-$31.88 (-4.2%)
Closing Price on January 17, 2025

LLY Articles

For those looking to generate income, equities remain one of the best resources, and these five look like long-term winners.
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
In a recent research note, the analysts at Merrill Lynch make a big move by removing two blue chips from the firm's well-respected US 1 list of stocks to buy.
This trading week has been shorter than most with Thanksgiving taking place on Thursday. As a result not too many companies have released news, updates or earnings this week, despite the markets...
Eli Lilly & Co. (NYSE: LLY) is watching its shares in free fall on Wednesday, not from any election or political concerns but a late-stage trial failure. As we have said time and again, clinical...
Now is a good time to add quality stocks in front of what is usually a very good time of the year for equities. These four stocks offer investors solid upside potential.
The analysts at Merrill Lynch have made a big move by adding a top property and casualty company to the firm's well-respected US 1 list of stocks to Buy.
The recent headlines and the huge Trump following have helped closed the gap on Clinton, and if Trump is declared the winner, we could see a large market drop next week.
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
A UBS research report notes the segments of the economy that may disproportionately benefit as all the money that baby boomers had stashed away in savings, pensions, IRAs and 401(k) plans starts to...
Eli Lilly plans to release its most recent earnings report before the markets open on Tuesday, and analysts expect top and bottom line growth.
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
A recent Merrill Lynch research features a big move by adding a top consumer goods company to the firm's well-respected US 1 list.
A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good sense for long-term growth and income portfolios.
One smart thing for growth stock buyers is to focus on total return and buy large cap quality stocks that will do well regardless of the near-term economic news.
AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.